{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T08:01:27Z","timestamp":1784707287454,"version":"3.55.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,22]]},"DOI":"10.7759\/cureus.113136","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T07:14:21Z","timestamp":1784704461000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinically Suspected Atypical Pantothenate Kinase-Associated Neurodegeneration Without the Eye-of-the-Tiger Sign: A Case Report"],"prefix":"10.7759","author":[{"given":"Rasika","family":"Rode","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preetam","family":"Salunkhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayshree","family":"Madavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratiksha","family":"Virdande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Pantothenate Kinase-Associated Neurodegeneration","author":"Gregory A","year":"2002","unstructured":"Gregory A, Hayflick SJ. Pantothenate Kinase-Associated Neurodegeneration. GeneReviews\u00ae. 2002."},{"key":"ref2","article-title":"Neurodegeneration with Brain Iron Accumulation Disorders Overview","author":"Gregory A","year":"2013","unstructured":"Gregory A, Kurian MA, Wilson J, Hayflick SJ. Neurodegeneration with Brain Iron Accumulation Disorders Overview. GeneReviews\u00ae. 2013."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/ng572","article-title":"A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome","volume":"28","author":"Zhou B","year":"2001","unstructured":"Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, Hayflick SJ. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet. 2001, 28:345-9. 10.1038\/ng572","journal-title":"Nat Genet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A5514","article-title":"Looking deep into the eye-of-the-tiger in pantothenate kinase-associated neurodegeneration","volume":"39","author":"Lee JH","year":"2018","unstructured":"Lee JH, Gregory A, Hogarth P, Rogers C, Hayflick SJ. Looking deep into the eye-of-the-tiger in pantothenate kinase-associated neurodegeneration. AJNR Am J Neuroradiol. 2018, 39:583-8. 10.3174\/ajnr.A5514","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1285925","article-title":"The \"eye-of-the-tiger\" sign may be absent in the early stages of classic pantothenate kinase associated neurodegeneration","volume":"42","author":"Chiapparini L","year":"2011","unstructured":"Chiapparini L, Savoiardo M, D'Arrigo S, et al.. The \"eye-of-the-tiger\" sign may be absent in the early stages of classic pantothenate kinase associated neurodegeneration. Neuropediatrics. 2011, 42:159-62. 10.1055\/s-0031-1285925","journal-title":"Neuropediatrics"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.22884","article-title":"Missense PANK2 mutation without \"eye of the tiger\" sign: MR findings in a large group of patients with pantothenate kinase-associated neurodegeneration (PKAN)","volume":"35","author":"Delgado RF","year":"2012","unstructured":"Delgado RF, Sanchez PR, Speckter H, et al.. Missense PANK2 mutation without \"eye of the tiger\" sign: MR findings in a large group of patients with pantothenate kinase-associated neurodegeneration (PKAN). J Magn Reson Imaging. 2012, 35:788-94. 10.1002\/jmri.22884","journal-title":"J Magn Reson Imaging"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2018.10.090","article-title":"Magnetic resonance imaging, susceptibility weighted imaging and quantitative susceptibility mapping findings of pantothenate kinase-associated neurodegeneration","volume":"59","author":"Zeng J","year":"2019","unstructured":"Zeng J, Xing W, Liao W, Wang X. Magnetic resonance imaging, susceptibility weighted imaging and quantitative susceptibility mapping findings of pantothenate kinase-associated neurodegeneration. J Clin Neurosci. 2019, 59:20-8. 10.1016\/j.jocn.2018.10.090","journal-title":"J Clin Neurosci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.01024","article-title":"Brain MRI pattern recognition in neurodegeneration with brain iron accumulation","volume":"11","author":"Lee JH","year":"2020","unstructured":"Lee JH, Yun JY, Gregory A, Hogarth P, Hayflick SJ. Brain MRI pattern recognition in neurodegeneration with brain iron accumulation\r\n. Front Neurol. 2020, 11:1024. 10.3389\/fneur.2020.01024","journal-title":"Front Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.14802\/jmd.14034","article-title":"Neurodegeneration with brain iron accumulation: diagnosis and management","volume":"8","author":"Hogarth P","year":"2015","unstructured":"Hogarth P. Neurodegeneration with brain iron accumulation: diagnosis and management. J Mov Disord. 2015, 8:1-13. 10.14802\/jmd.14034","journal-title":"J Mov Disord"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27563","article-title":"Deep brain stimulation for pantothenate kinase-associated neurodegeneration: a meta-analysis","volume":"34","author":"De Vloo P","year":"2019","unstructured":"De Vloo P, Lee DJ, Dallapiazza RF, et al.. Deep brain stimulation for pantothenate kinase-associated neurodegeneration: a meta-analysis. Mov Disord. 2019, 34:264-73. 10.1002\/mds.27563","journal-title":"Mov Disord"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30142-5","article-title":"Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study","volume":"18","author":"Klopstock T","year":"2019","unstructured":"Klopstock T, Tricta F, Neumayr L, et al.. Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study. Lancet Neurol. 2019, 18:631-42. 10.1016\/S1474-4422(19)30142-5","journal-title":"Lancet Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/484980-clinically-suspected-atypical-pantothenate-kinase-associated-neurodegeneration-without-the-eye-of-the-tiger-sign-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T07:14:22Z","timestamp":1784704462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/484980-clinically-suspected-atypical-pantothenate-kinase-associated-neurodegeneration-without-the-eye-of-the-tiger-sign-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.113136","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,22]]}}}